EUVIMEDEUVIMED entdecken
Crossref

II Konferencja Otyłość Wieku Rozwojowego – od przyczyn do konsekwencji

Nutrition, Obesity & Metabolic Surgery · 2018

DOI: 10.5114/noms.2018.78925 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, Obesity & Metabolic Surgery, 2018.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HyOb is a complex disease derived from damage to several hypothalamic nuclei that includes leptin resistance and hyperleptinemia, melanocortin deficiency and resistance due to MC4R damage, modulation of POMC and NPY, oxytocin and CRH, finally affecting food intake and weight gain.At the end-organ targets, HyOb leads to enhanced 11β-hydroxysteroid dehydrogenase-1 activity, a decrease in sympathetic tone and increases in vagal tone, resulting in insulin hypersecretion.Attempts to ameliorate only one of these agents have been used for limited periods in a small number of patients with limited success.Conclusion: The complexity of HyOb requires a strategy, probably multi-drug, of simultaneous targeting as many as possible of these mechanisms, adjuncts to behavioral and lifestyle changes.

Zitieren

APA

(2018). II Konferencja Otyłość Wieku Rozwojowego – od przyczyn do konsekwencji. Nutrition, Obesity & Metabolic Surgery. https://doi.org/10.5114/noms.2018.78925

Vancouver

II Konferencja Otyłość Wieku Rozwojowego – od przyczyn do konsekwencji. Nutrition, Obesity & Metabolic Surgery. 2018. doi:10.5114/noms.2018.78925

BibTeX
@article{euvimed2018,
  title = {II Konferencja Otyłość Wieku Rozwojowego – od przyczyn do konsekwencji},
  journal = {Nutrition, Obesity & Metabolic Surgery},
  year = {2018},
  doi = {10.5114/noms.2018.78925}
}
Kostenlos starten →